Amplification of the MYCN oncogene has been observed in retinoblastoma, glioblastoma, and medulloblastoma tumors [125], and raises the possibility that TRIM32 plays a broader role in tumor suppression than previously thought. The gene discussed is MYCN; the disease is neoplasm.